IRINOTESIN 500mg/25mL irinotecan hydrochloride trihydrate 500mg/25mL concentrated injection vial

Country: Australia

Bahasa: Inggeris

Sumber: Department of Health (Therapeutic Goods Administration)

Beli sekarang

Download Laporan Penilaian Awam (PAR)
29-11-2017

Bahan aktif:

irinotecan hydrochloride trihydrate, Quantity: 500 mg

Boleh didapati daripada:

Medis Pharma Pty Ltd

INN (Nama Antarabangsa):

irinotecan hydrochloride trihydrate

Borang farmaseutikal:

Injection, concentrated

Komposisi:

Excipient Ingredients: sorbitol; lactic acid; sodium hydroxide; hydrochloric acid; water for injections

Laluan pentadbiran:

Intravenous Infusion

Unit dalam pakej:

One

Jenis preskripsi:

(S4) Prescription Only Medicine

Tanda-tanda terapeutik:

Indicated as a component of first line therapy for patients with metastatic carcinoma of the colon or rectum. Also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy

Ringkasan produk:

Visual Identification: Irinotecan is supplied in brown type 1 glass vial, containing a clear to pale yellow solution, stoppered by a bromobutylic rubber stopper and sealed with a aluminium crimp and a propylene disc.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Status kebenaran:

Licence status A

Tarikh kebenaran:

2011-07-11